(RTTNews) - Iovance Biotherapeutics (IOVA), a biotechnology company, on Thursday announced the appointment of Noah Berkowitz as Chief Medical Officer, effective September 30.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.